Abstract
Previous studies have indicated a role for glucosylceramide synthase (GCS) in multidrug resistance (MDR), either related to turnover of ceramide (Cer) or generation of gangliosides, which modulate apoptosis and/or the activity of ABC transporters. This study challenges the hypothesis that gangliosides modulate the activity of ABC transporters and was performed in two human neuroblastoma cell lines, expressing either functional P-glycoprotein (Pgp) or multidrug resistance-related protein 1 (MRP1). Two inhibitors of GCS, D,L-threo-1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol (t-PPPP) and N-butyldeoxynojirimycin (NB-dNJ), very efficiently depleted ganglioside content in two human neuroblastoma cell lines. This was established by three different assays: equilibrium radiolabeling, cholera toxin binding, and mass analysis. Fluorescence-activated cell sorting (FACS) analysis showed that ganglioside depletion only slightly and in the opposite direction affected Pgp- and MRP1-mediated efflux activity. Moreover, both effects were marginal compared with those of well-established inhibitors of either MRP1 (i.e., MK571) or Pgp (i.e., GF120918). t-PPPP slightly enhanced cellular sensitivity to vincristine, as determined by 3-[4,5-dimethylthiazol-2-yl]2,5-diphenyl tetrazolium bromide analysis, in both neuroblastoma cell lines, whereas NB-dNJ was without effect. MRP1 expression and its localization in detergent-resistant membranes were not affected by ganglioside depletion. Together, these results show that gangliosides are not relevant to ABC transporter-mediated MDR in neuroblastoma cells.
Highlights
Previous studies have indicated a role for glucosylceramide synthase (GCS) in multidrug resistance (MDR), either related to turnover of ceramide (Cer) or generation of gangliosides, which modulate apoptosis and/or the activity of ABC transporters
The initial observation was that the adriamycin-resistant MCF-7 human breast cancer cell line MCF-7-AdrR accumulated glucosylceramide, which is the product of ceramide (Cer) glycosylation by glucosylceramide synthase (GCS) [5]
Evidence has been obtained for gangliosides GD3 and GM3 as Pgp regulators through the modulation of Pgp phosphorylation in acute myeloid leukemia cells [23]
Summary
Previous studies have indicated a role for glucosylceramide synthase (GCS) in multidrug resistance (MDR), either related to turnover of ceramide (Cer) or generation of gangliosides, which modulate apoptosis and/or the activity of ABC transporters. We efficiently inhibited ganglioside biosynthesis in parallel using two different inhibitors of GCS, D,L-threo-1-phenyl-2-hexadecanoylamino-3pyrrolidino-1-propanol (t-PPPP) and N-butyldeoxynojirimycin (NB-dNJ). We have established that in human neuroblastoma cells, gangliosides do not significantly modulate ABC transporter function.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have